Evidence map›Paper›PMID 40718314›Full record

ArticleCureus2025

Beneficial Effects of Caraway Oil in Aluminium Chloride-Induced Neurotoxicity.

Sandip T Auti, Yogesh A Kulkarni

Abstract read
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Sensory Perception of Six Essential Oils in Humans andMolecules (Basel, Switzerland) · 2026
    Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sandip T AutiShobhaben Paratapbhai Patel School of Pharmacy and Technology Management, SVKM's Narsee Monjee Institute of Management Studies (NMIMS), Deemed to be University, Mumbai, IND.
Yogesh A KulkarniShobhaben Paratapbhai Patel School of Pharmacy and Technology Management, SVKM's Narsee Monjee Institute of Management Studies (NMIMS), Deemed to be University, Mumbai, IND.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeAlzheimer's disease (AD) is characterized by cognitive decline and memory impairment, amyloid plaques, and neurofibrillary tangles (NFT). Current therapies provide symptomatic treatment but do not address the exact cause of the disease. Caraway oil, derived from

methodsAlbino Wistar rats were randomized into five groups: normal control, disease control (aluminum chloride, 100 mg/kg), standard (donepezil, 1 mg/kg), and caraway oil treatment groups (100 and 200 mg/kg). Treatments were administered orally for 42 days. Behavioral assessments included locomotor activity, the Morris water maze, the elevated plus maze, and passive avoidance tests. Acetylcholinesterase (AChE) activity and oxidative stress markers were assessed in the hippocampus and cortex.

resultsCaraway oil administration significantly improved locomotor activity and spatial memory in rats at 100 mg/kg and 200 mg/kg. The oil showed a significant effect on oxidative stress parameters in the hippocampus and cortex. AChE activity was also improved significantly (p<0.001) after caraway oil treatment.

conclusionCaraway oil demonstrated significant neuroprotective effects in aluminum chloride-induced neurotoxicity, improving cognitive and behavioral functions and reducing oxidative stress. These findings suggest that caraway oil may have therapeutic potential in the management of AD.

Indexed as

acetylcholinesterasealuminium chloridealzheimer's diseasecaraway oilneuroprotective

Identifiers

PMID40718314
PMCPMC12296912

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.